Back to search

University of Sheffield

Quality and clinical utility of genomic variants in complex diseases

Abstract

dc:description.abstract

Continuous improvements in high-throughput genomic sequencing over the past two decades have made it exponentially faster and cheaper, enabling its routine use in the clinic and scientific research. Genomic prognostic tools make use of personalised genomic data to aid clinical decision making and inform patients of disease outcomes, allowing enhanced tailoring of treatment beyond traditional prognostic tools, which are insufficient for understanding the nuances of individual complex disease cases. This relies upon accurate sequencing data and effective quality control. We have developed improved genomic prognostic tools for use in the clinic and demonstrate a novel method for quality control of genomic sequencing data with broad applicability. Non-small-cell lung cancer (NSCLC) is the second most common cancer type in both males and females globally. Previous attempts to predict survival time for cancer patients have used genomic prognostic tools based on the burden of tumour mutations and neoantigens, but with limited success. We developed greatly improved classifiers of tumour mutation and neoantigenic burden showing strong 5-year survival differences between early-stage NSCLC patients. By using these together, we showed additional increases in prognostic efficacy, with the best survival group displaying a ~92% decreased risk of death in a 5-year period compared to the worst survival group. To improve the accuracy of sequencing data for uses such as this, we developed the first tool for automatically cataloguing systematic sequencing biases for a sequencing pipeline, and we demonstrated its value in human and SARS-CoV-2 sequencing quality control with Illumina and Oxford Nanopore sequencing. We discovered and blacklisted a range of false positive variants, and investigated the causes of these. Identifying these errors contributed to multiple studies, altering research conclusions. We share these tools to provide continued improvements to genomic prognostics and sequencing accuracy affecting a wide range of fields.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Freeman, Timothy Martin
Advisor dc:contributor.advisor
  • Wang, Dennis
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.846601

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Freeman, Timothy Martin. Quality and clinical utility of genomic variants in complex diseases. doctoral thesis, University of Sheffield, 2021.